| SRDX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SRDX market cap history going back to 2/3/2010:
Also see: SRDX Shares Outstanding History and SRDX YTD Return |
As of 8/1/2025 Surmodics has a market cap of 515.14 million. Investors often follow the SRDX market cap history to compare the size of the company over time.
This page shows SRDX market capitalization trends over time, with 62 market cap datapoints presented, dating back to 2/3/2010.

| SRDX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SRDX market cap history going back to 2/3/2010:
Also see: SRDX Shares Outstanding History and SRDX YTD Return |
| SRDX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SRDX Historical Market Cap: +2.54% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SRDX Stock Price Chart |
| About Surmodics Inc |
| Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. We show 62 historical shares outstanding datapoints in our SRDX shares outstanding history coverage, used to compute SRDX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SRDX market cap history over the course of time is important for investors interested in comparing SRDX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SRDX versus a peer is one thing; comparing SRDX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SRDX can fluctuate over the course of history. With this page we aim to empower investors researching SRDX by allowing them to research the SRDX market cap history. |
| SRDX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| SRDX Share Performance |
| Market Cap Peers |
| Surmodics (SRDX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SRGA Market Cap History SRNE Market Cap History SRPT Market Cap History SRRA Market Cap History SRRK Market Cap History SRTS Market Cap History SRZN Market Cap History SSII Market Cap History SSKN Market Cap History STAA Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.